Human platelet cGI-PDE: Expression in yeast and localization of the catalytic domain by deletion mutagenesis

Blood

Volumn 88, Issue 4, 1996, Pages 1321-1329

  Cheung, Peter P ^a   Xu, Hui ^b   McLaughlin, Megan M ^b   Ghazaleh, Faika A ^b   Livi, George P ^b   Colman, Robert W ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP PHOSPHODIESTERASE;

ARTICLE; CATALYSIS; CONTROLLED STUDY; DELETION MUTANT; DNA LIBRARY; DNA SEQUENCE; ENZYME ACTIVE SITE; ERYTHROLEUKEMIA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SACCHAROMYCES CEREVISIAE;

EID: 0029797257     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.4.1321.bloodjournal8841321     Document Type: Article

References (55)

1. Sassone-Corsi P: Goals for signal transduction pathways: Linking up with transcriptional regulation (review). EMBO J 13:4717, 1994
2. Aronica SM, Kraus WL, Katzenellenbogen BS: Estrogen action via the cAMP signaling pathway: Stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci USA 91:8517, 1994
3. Baukal AJ, Hunyady L, Catt KJ, Balla T: Evidence for participation of calcineurin in potentiation of agonist-stimulated cyclic AMP formation by the calcium-mobilizing hormone, angiotensin II. J Biol Chem 269:24546, 1994
4. Nagy LE, DeSilva SE: Adenosine A1 receptors mediate chronic ethanol-induced increases in receptor-stimulated cyclic AMP in cultured hepatocytes. Biochem J 304:205, 1994
5. Shabb JB, Buzzeo BD, Ng L, Corbin JD: Mutating protein kinase cAMP-binding sites into cGMP-binding sites. Mechanism of cGMP selectivity. J Biol Chem 266:24320, 1991
6. Schneck J, Rager-Zisman B, Rosen OM, Bloom BR: Genetic analysis of the role of cAMP in mediating effects of interferon. Proc Natl Acad Sci USA 79:1879, 1982
7. Salzman EW, Weisenberger H: Role of cyclic AMP in platelet function (review). Adv Cyclic Nucleotide Res 1:231, 1972
8. Beavo JA, Conti M, Heaslip RJ: Multiple cyclic nucleotide phosphodiesterases. Mol Pharmacol 46:399, 1994
9. Conti M, Jin SL, Monaco L, Repaske DR, Swinnen JV: Hormonal regulation of cyclic nucleotide phosphodiesterases [review]. Endocr Rev 12:218, 1991
10. Alvarez R, Taylor A, Fazzari JJ, Jacobs JR: Regulation of cyclic AMP metabolism in human platelets. Sequential activation of adenylate cyclase and cyclic AMP phosphodiesterase by prostaglandins. Mol Pharmacol 20:302, 1981
11. Macphee CH, Reifsnyder DH, Moore TA, Lerea KM, Beavo JA: Phosphorylation results in activation of a cAMP phosphodiesterase in human platelets. J Biol Chem 263:10353, 1988
12. Grant PG, Mannarino AF, Colman RW: cAMP-mediated phosphorylation of the low-Km cAMP phosphodiesterase markedly stimulates its catalytic activity. Proc Natl Acad Sci USA 85:9071, 1988
13. Gettys TW, Vine AJ, Simonds MF, Corbin JD: Activation of the particulate low Km phosphodiesterase of adipocytes by addition of cAMP-dependent protein kinase. J Biol Chem 263:10359, 1988
14. Beavo JA: Multiple isozymes of cyclic nucleotide phosphodiesterase [review]. Adv Second Messenger Phosphoprotein Res 22:1, 1988
15. Charbonneau H, Prusti RK, LeTrong H, Sonnenburg WK, Mullaney PJ, Walsh KA, Beavo JA: Identification of a noncatalytic cGMP-binding domain conserved in both the cGMP-stimulated and photoreceptor cyclic nucleotide phosphodiesterases. Proc Natl Acad Sci USA 87:288, 1990
16. Grant PG, Mannarino AF, Colman RW: Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from the cytosol of human platelets. Thromb Res 59:105, 1990
17. Meacci E, Taira M, Moos M Jr, Smith CJ, Movsesian MA, Degerman E, Belfrage P, Manganiello V: Molecular cloning and expression of human myocardial cGMP-inhibited cAMP phosphodiesterase. Proc Natl Acad Sci USA 89:3721, 1992
18. Simpson AW, Reeves ML, Rink TJ: Effects of SK&F 94120, an inhibitor of cyclic nucleotide phosphodiesterase type III, on human platelets. Biochem Pharmacol 37:2315, 1988
19. Beavo JA, Reifsnyder DH: Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors [review]. Trends Pharmacol Sci 11:150, 1990
20. Hall IP: Isoenzyme selective phosphodiesterase inhibitors: Potential clinical uses [review], Br J Clin Pharmacol 35:1, 1993
21. Murray KJ, England PJ: Inhibitors of cyclic nucleotide phosphodiesterases as therapeutic agents [review]. Biochem Soc Trans 20:460, 1992
22. Saitoh S, Saito T, Otake A, Owada T, Mitsugi M, Hashimoto H, Maruyama Y: Cilostazol, a novel cyclic AMP phosphodiesterase inhibitor, prevents reocclusion after coronary arterial thrombolysis with recombinant tissue-type plasminogen activator. Arterioscler Thromb 13:563, 1993
23. Simpson AW, Reeves ML, Rink TJ: Effects of SK&F 94120, an inhibitor of cyclic nucleotide phosphodiesterase type III, on human platelets. Biochem Pharmacol 37:2315, 1988
24. Murray KJ, England PJ, Hallam TJ, Maguire J, Moores K, Reeves ML, Simpson AW, Rink TJ: The effects of siguazodan, a selective phosphodiesterase inhibitor, on human platelet function. Br J Pharmacol 99:612, 1990
25. Masuoka H, Ito M, Sugioka M, Kozeki H, Konishi T, Tanaka T, Nakano T: Two isoforms of cGMP-inhibited cyclic nucleotide phosphodiesterases in human tissues distinguished by their responses to vesnarinone, a new cardiotonic agent. Biochem Biophys Res Commun 190:412, 1993
26. Grant PG, Colman RW: Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase. Biochemistry 23:1801, 1984
27. Pillai R, Staub SF, Colicelli J: Mutational mapping of kinetic and pharmacological properties of a human cardiac cAMP phosphodiesterase. J Biol Chem 269:30676, 1994
28. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
29. Williams JG, Mason PJ: Hybridization in the analysis of RNA, in Hanes BD, Higgins SJ (eds): Nucleic Acid Hybridization. Washington, DC, IRL, 1987, 139
30. Feinberg AP, Vogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6, 1983
31. Huynh TV, Young RA, Davis RW: Construction and screening cDNA libraries in λgt10 and λgt11, in Glover DM (ed): DNA Cloning: A Practical Approach. Washington, DC, IRL, 1985, 49
32. McHale MM, Cieslinski LB, Eng WK, Johnson RK, Torphy TJ, Livi GP: Expression of human recombinant cAMP phosphodiesterase isozyme IV reverses growth arrest phenotypes in phosphodiesterase-deficient yeast. Mol Pharmacol 39:109, 1991
33. McLaughlin MM, Cieslinski LB, Burman M, Torphy TJ, Livi GP: A low-km rolipram-sensitive, cAMP-specific phosphodiesterase form human brain. Cloning and expression of cDNA, biochemical characterization of recombinant protein, and tissue distribution of mRNA. J Biol Chem 268:6470, 1993
34. Hicks JB, Herskowitz I: Evidence for a new diffusible element of mating pheromones in yeast. Nature 260:246, 1976
35. Ito H, Fukuda Y, Murata K, Kimura A: Transformation of intact yeast cells treated with alkali cations. J Bacteriol 153:163, 1983
36. Sinha AK, Shattil SJ, Colman RW: Cyclic AMP metabolism in cholesterol-rich platelets. J Biol Chem 252:3310, 1977
37. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680, 1970
38. Sambrook J, Fritsch EF, Maniatus T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
39. Martin P, Papayannopoulou T: HEL cells: A new human erythroleukemia cell line with spontaneous and induced globin expression. Science 216:1233, 1982
40. Tabilio A, Rosa JP, Testa U, Kieffer N, Nurden AT, Del Canizo MC, Breton-Gorius J, Vainchenker W: Expression of platelet membrane glycoproteins and alpha-granule proteins by a human erythroleukemia cell line (HEL). EMBO J 3:453, 1984
41. Ito T, Ogura M, Morishita Y, Takamatsu J, Maruyama I, Yamamoto S, Ogawa K, Saito H: Enhanced expression of thrombomodulin by intracellular cyclic AMP-increasing agents in two human megakaryoblastic leukemia cell lines. Thromb Res 58:615, 1990
42. Shi XP, Yin KC, Gardell SJ: Human erythroleukemic (HEL) cells express a platelet P2T-like ADP receptor. Thromb Res 77:235, 1995
43. Poncz M, Surrey S, LaRocco P, Weiss MJ, Rappaport EF, Conway TM, Schwartz E: Cloning and characterization of platelet factor 4 cDNA derived from a human erythroleukemic cell line. Blood 69:219, 1987
44. Wenger RH, Wicki AN, Walz A, Kieffer N, Clemetson KJ: Cloning of cDNA coding for connective tissue activating peptide III from a human platelet-derived lambda gt11 expression library. Blood 73:1498, 1989
45. Kasuya J, Goko H, Fujita-Yamaguchi Y: Multiple transcripts for the human cardiac form of the cGMP-inhibited cAMP phosphodiesterase. J Biol Chem 270:14305, 1995
46. Degerman E, Moos M Jr, Rascon A, Vasta V, Meacci E, Smith CJ, Lindgren S, Andersson K-E, Belfrage C, Manganiello V: Single-step affinity purification, partial structure and properties of human platelet cGMP inhibited cAMP phosphodiesterase. Biochim Biophys Acta 1205:189, 1994
47. Grant PG, Colman RW: Purification of cAMP phosphodiesterase from platelets. Methods Enzymol 159:772, 1988
48. Litt M, Luty JA: A hypervariable microsatellite revealed by in vitro amplification of a dinucleotide repeat within the cardiac muscle actin gene. Am J Hum Genet 44:397, 1989
49. Weber B, Riess O, Daneshvar H, Graham R, Hayden MR: (CA)n-dinucleotide repeat at the PDEB locus in 4p16.3. Hum Mol Genet 2:827, 1993
50. Jin SL, Swinnen JV, Conti M: Characterization of the structure of a low Km, rolipram-sensitive cAMP phosphodiesterase. Mapping of the catalytic domain. J Biol Chem 267:18929, 1992
51. Taira M, Hockman SC, Calvo JC, Belfrage P, Manganiello VC: Molecular cloning of the rat adipocyte hormone-sensitive cyclic GMP-inhibited cyclic nucleotide phosphodiesterase. J Biol Chem 268:18573, 1993
52. Charbonneau H, Beier N, Walsh KA, Beavo JA: Identification of a conserved domain among cyclic nucleotide phosphodiesterases from diverse species. Proc Natl Acad Sci USA 83:9308, 1986
53. Torphy TJ, Stadel JM, Burman MN, Cieslinski LB, McLaughlin MM, White JR, Livi GP: Co-expression of human cAMP-specific phosphodiesterase activity and high affinity rolipram binding in yeast. J Biol Chem 267:1798, 1992
54. Omburo GA, Brickus T, Ghazaleh FA, Colman RW: Divalent metal cation requirement and possible classification of cGMP-inhibited phosphodiesterase as a metallohydrolase. Arch Biochem Biophys 323:1, 1995
55. Francis SH, Colbran JL, McAllister-Lucas LM, Corbin JD: Zinc interactions and conserved motifs of the cGMP-binding cGMP-specific phosphodiesterase suggest that it is a zinc hydrolase. J Biol Chem 269:22477, 1994